Bank Of New York Mellon Corp Biogen Inc. Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$256.56 - $292.34 $378 Million - $431 Million	1,474,178 New	1,474,178 $410 Billion
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $382 Million - $464 Million	1,512,956 New	1,512,956 $419 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $6.73 Million - $9.28 Million	-34,555 Reduced 2.24%	1,506,789 $402 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $19.5 Million - $23.2 Million	104,133 Added 7.25%	1,541,344 $314 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $5.44 Million - $6.86 Million	-28,096 Reduced 1.92%	1,437,211 $303 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $32.4 Million - $41.6 Million	-144,492 Reduced 8.98%	1,465,307 $352 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $44.2 Million - $57.6 Million	-156,033 Reduced 8.84%	1,609,799 $456 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $107 Million - $171 Million	-411,266 Reduced 18.89%	1,765,832 $611 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $7.53 Million - $8.83 Million	31,006 Added 1.44%	2,177,098 $609 Million
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $39.1 Million - $58.8 Million	-165,321 Reduced 7.15%	2,146,092 $525 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $2.02 Million - $2.34 Million	-7,639 Reduced 0.33%	2,311,413 $656 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $24.3 Million - $32.1 Million	-93,808 Reduced 3.89%	2,319,052 $620 Million
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $79.5 Million - $101 Million	295,556 Added 13.96%	2,412,860 $763 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $49.7 Million - $68.7 Million	225,925 Added 11.94%	2,117,304 $628 Million
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $35.6 Million - $40 Million	163,894 Added 9.49%	1,891,379 $440 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $35.3 Million - $38.9 Million	-160,864 Reduced 8.52%	1,727,485 $404 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $75.4 Million - $118 Million	-347,818 Reduced 15.55%	1,888,349 $446 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $18.4 Million - $23.2 Million	-65,895 Reduced 2.86%	2,236,167 $673 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $17.6 Million - $23.1 Million	-60,074 Reduced 2.54%	2,302,062 $0
Q2 2018 Aug 06, 2018	BUY	$257.52 - $306.91 $18.7 Million - $22.3 Million	72,668 Added 3.17%	2,362,136 $686 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $26.3 Million - $37.2 Million	-101,059 Reduced 4.23%	2,289,468 $627 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $735 Million - $824 Million	2,390,527	2,390,527 $762 Million

Others Institutions Holding BIIB

# of Institutions

994

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account